✦ LIBER ✦

LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer

✍ Scribed by J. PATTAMADILOK; N. HUAPAI; P. RATTANATANYONG; A. VASURATTANA; S. TRIRATANACHAT; D. TRESUKOSOL; A. MUTIRANGURA

Book ID: 109086320
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 160 KB
Volume: 18
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2007.01117.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preoperative CA125 as a prognostic facto

Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer

✍ ANETTE LYKKE PETRI; ESTRID HØGDALL; IB JARLE CHRISTENSEN; SUSANNE KRÜGER KJAER; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Interleukin-6 level in serum and ascites

Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer

✍ Marie Plante; Stephen C. Rubin; George Y. Wong; Mark G. Federici; Connie L. Fins 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

Background. Interleukin-6 (IL-6) is a multifunctional cytokine that can be produced by human ovarian cancer cells. Elevated IL-6 levels have been found in the serum and ascites of patients with ovarian cancer, but its role in this disease has not been clearly established. Methods. The authors studi

Prognostic factors for high-risk early-s

Prognostic factors for high-risk early-stage epithelial ovarian cancer : A Gynecologic Oncology Group study

✍ John K. Chan; Chunqiao Tian; Bradley J. Monk; Thomas Herzog; Daniel S. Kapp; Jef 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Abstract ## BACKGROUND. The purpose was to identify the factors predictive of recurrence and survival in patients with high‐risk (stage I, grade 3; stage IC, stage II, or clear cell) epithelial ovarian cancer after adjuvant therapy. ## METHODS. Data was extracted from patients who underwent p

Plasminogen activator inhibitor-1 is an

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB 👁 2 views

High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co

Preoperative serum level of inhibin A is

Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma

✍ Antonio E. Frias Jr.; Honghze Li; Gary L. Keeney; Karl C. Podratz; Teresa K. Woo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Background: The aim of this study was to determine the prognostic significance of preoperative serum inhibin and activin levels in postmenopausal women with epithelial ovarian carcinoma (eoc) by correlating serum levels with disease parameters, including tumor stage and grade and patient age. #

Expression of plasminogen activator inhi

Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer: A favorable prognostic factor related to the actions of CSF-1

✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB 👁 2 views

In ovarian cancer cells, the macrophage colony-stimulating factor-1 (CSF-1) induces the release of plasminogen activator inhibitor-2 (PAI-2), and high levels of PAI-2 as well as of CSF-1 in ovarian cancer ascites are independently correlated with poor outcome. We now study the effect of CSF-1 on PAI